Mercy Bio

Mercy BioAnalytics is a biotech innovator developing the Mercy Halo™ extracellular vesicle-based liquid biopsy platform to detect cancers like ovarian and lung at earlier, more treatable stages through sensitive, non-invasive blood tests that aim to improve survival and patient outcomes.

Investment Details

Portfolia Fund

Funding Round

Series B

Milestones

Funded in 2025

About the Founder

Dawn Mattoon

Dr. Dawn Mattoon possesses a proven track record of delivering top and bottom-line growth as a leader in research and development, strategy, and general management for companies such as Invitrogen, Life Technologies, Thermo Fisher Scientific Inc. (NYSE: TMO), and Cell Signaling Technologies. Most recently, Dr. Mattoon served as Senior Vice President of Clinical Diagnostics at Quanterix Corporation (Nasdaq: QTRX), where she led the development and commercialization of the company’s first FDA-authorized diagnostic tests for COVID-19 and received FDA Breakthrough Device designations for diagnostic tests addressing Alzheimer’s Disease and Multiple Sclerosis. She holds a PhD in molecular genetics from Yale University, where she also completed her postdoctoral fellowship.

Real Investors. Real Outcomes.

“I have learned so much about leadership, financial well-being, and the power of connection from the amazing community of women at Portfolia.”

Peggy Northrop

CEO of Watermark and Former Editor-in-Chief of More Magazine, Connecticut

“I love the concept of being able to invest and collaborate with others, mitigating my own risk by investing in a portfolio. It lets me see more deals in the pipeline.”

Chantell Preston

Healthcare Executive, Houston, TX

“I joined because I was excited that the model was more like a mutual fund and offered exposure to so many companies and opportunities to further learning.”

Namrita Kapur

Fellow, Yale School of Management, Boston, MA

“I have learned so much about leadership, financial well-being, and the power of connection from the amazing community of women at Portfolia.”

Peggy Northrop

CEO of Watermark and Former Editor-in-Chief of More Magazine, Connecticut

“I love the concept of being able to invest and collaborate with others, mitigating my own risk by investing in a portfolio. It lets me see more deals in the pipeline.”

Chantell Preston

Healthcare Executive, Houston, TX

“I joined because I was excited that the model was more like a mutual fund and offered exposure to so many companies and opportunities to further learning.”

Namrita Kapur

Fellow, Yale School of Management, Boston, MA

Spotlight

Heading

Start Your Investing Journey with Portfolia

Our live overview sessions are the best way to experience how Portfolia is transforming venture capital and why the experience is unmatched.

MEET OUR PARTNERS
LEARN HOW OUR FUNDS WORK
SEE THE COMPANIES WE'RE BACKING.